Arkolith/Insider Trading/STOK/Form 4

Leggett Thomas

Chief Financial OfficerStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Feb 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Grant(A)60K—$060K
Feb 17, 2026Grant(A)40K—$040K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001774690-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML